We’re excited to be working with @JNJInnovation to accelerate the path to new medicines. This collaboration brings @IsomorphicLabs
' AI drug design engine together with J&J’s world-class drug development capabilities to tackle historically difficult to drug disease targets. A big

→ View original post on X — @demishassabis,